cell-penetrating peptide vaccine (University of Geneva)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecell-penetrating peptide vaccine (University of Geneva)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Geneva

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Geneva

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A